A comprehensive view of FDA Drug/Device Reviews. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA to convene advisors to review experimental RSV vaccine candidate from Pfizer on February 28; group to meet in March to reviews RSV vaccine candidate from GSK
Published: February 03, 2023 by BioPharma Dive
Some FDA advisers upset that early data about new Moderna COVID-19 booster shot wasn't presented during approval review, citing lack of transparency in process; early, limited data suggested booster may not be more effective than original vaccination
Published: January 12, 2023 by Philadelphia Tribune
Canopy Growth to collaborate with James Madison University on Phase 2 clinical trial to study effects of cannabidiol on menstrual-related symptoms; trial will include 33 participants in the US
Published: January 12, 2023 by Contify Life Science News
FDA grants priority review to Roche’s bispecific antibody glofitamab to treat relapsed or refractory large B-cell lymphoma; glofitamab would be first fixed-duration T-cell engaging bispecific antibody approved to treat aggressive non-Hodgkin lymphoma
Published: January 06, 2023 by GlobeNewswire Europe
Pfizer, partnering with Sosei Group, announces dosing of first subject in Phase 2 clinical trial of PF-07081532, a candidate for treatment of type 2 diabetes and obesity; trial marks a development milestone, triggering US$10M payment to Sosei
Published: December 21, 2022 by Globe Newswire

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count